Back to Trades
Sell4
MADRIGAL PHARMACEUTICALS, INC.
MDGL
Total Value
$1.1M
Net $1.1M sold
Sales
$1.1M
11 transactions
Company Information
- Company Name
- MADRIGAL PHARMACEUTICALS, INC.
- Ticker Symbol
- MDGL
- CIK
- 0001157601
Insider Information
- Name
- Huntsman Carole
- Role
- Chief Commercial Officer
- Location
- WEST CONSHOHOCKEN, PA
Officer
Filing Details
- Filing Date
- Nov 21, 2025
- Transaction Date
- Nov 21, 2025
- Accession Number
- 0001628280-25-053648
- Form Type
- 4
- Net Trading Amount
- -$1.1M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 21, 2025 | Common Stock | 894 | $550.97 | Sale | $492.6K |
| Nov 21, 2025 | Common Stock | 144 | $547.27 | Sale | $78.8K |
| Nov 21, 2025 | Common Stock | 120 | $548.71 | Sale | $65.8K |
| Nov 21, 2025 | Common Stock | 40 | $549.34 | Sale | $22.0K |
| Nov 21, 2025 | Common Stock | 200 | $552.38 | Sale | $110.5K |
| Nov 21, 2025 | Common Stock | 40 | $553.23 | Sale | $22.1K |
| Nov 21, 2025 | Common Stock | 120 | $556.04 | Sale | $66.7K |
| Nov 21, 2025 | Common Stock | 200 | $559.60 | Sale | $111.9K |
| Nov 21, 2025 | Common Stock | 80 | $560.62 | Sale | $44.8K |
| Nov 21, 2025 | Common Stock | 40 | $563.21 | Sale | $22.5K |
| Nov 21, 2025 | Common Stock | 80 | $564.56 | Sale | $45.2K |
Footnotes
- (F1)The sale reported on this line represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
- (F2)These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.
- (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.12 to $547.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
- (F4)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.25 to $548.94, inclusive.
- (F5)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.30 to $549.38, inclusive.
- (F6)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.96 to $552.81, inclusive.
- (F7)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.22 to $553.23, inclusive.
- (F8)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.74 to $556.19, inclusive.
- (F9)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $559.22 to $560.06, inclusive.
- (F10)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $560.24 to $561.00, inclusive.
- (F11)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.55 to $564.58, inclusive.